Orexo AB (publ) (STO:ORX)
17.48
+0.54 (3.19%)
At close: Feb 17, 2025
Orexo AB Employees
Orexo AB had 110 employees as of December 31, 2024. The number of employees decreased by 6 or -5.17% compared to the previous year.
Employees
110
Change (1Y)
-6
Growth (1Y)
-5.17%
Revenue / Employee
5.36M SEK
Profits / Employee
-1.85M SEK
Market Cap
588.66M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Swedish Orphan Biovitrum AB | 1,840 |
Getinge AB | 11,791 |
Sectra AB | 1,204 |
Camurus AB | 256 |
Medicover AB | 47,000 |
Vitrolife AB | 1,120 |
Elekta AB | 4,718 |
Vimian Group AB | 1,100 |
Orexo AB News
- 6 weeks ago - Orexo announces positive topline data from clinical study of OX640 in subjects with and without allergic rhinitis - PRNewsWire
- 2 months ago - Orexo, Abera to develop nasal powder vaccines based on AmorphOX technology - Seeking Alpha
- 2 months ago - Orexo enters into collaboration with Abera to develop nasal powder vaccines based on the AmorphOX technology - PRNewsWire
- 4 months ago - Orexo initiates new study of OX640 in participants with allergic rhinitis - PRNewsWire
- 4 months ago - Orexo AB reports Q3 results - Seeking Alpha
- 5 months ago - Orexo´s Nomination Committee for the Annual General Meeting 2025 - PRNewsWire
- 6 months ago - Orexo to participate in Pareto Securities´ 15th Annual Healthcare Conference 2024 - PRNewsWire
- 7 months ago - Orexo shares new information on OX124, a high-dose naloxone rescue medication in development for opioid overdose - PRNewsWire